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( Vitamin D deficiency is a prevalent and important global health problem. Because 
of its role in growth and development, vitamin D status is likely to be particularly important in 
adolescent girls. Here we explored the effects of high)dose vitamin D supplementation on 
cardiometabolic risk factors. 
)
 We have examined the effects of vitamin D supplementation on cardio)metabolic risk 
factors in 988 healthy adolescent girls in Iran. Fasting blood samples and anthropometric 
measurements were obtained at baseline and after supplementation with high dose vitamin D.  
All individuals took a capsule of 50000 IU vitamin D/ week for nine weeks. The study was 
completed by 940 participants. 

 the prevalence of vitamin D deficiency was 90% at baseline, reducing to16.3% after 
vitamin D supplementation. Vitamin supplementation was associated with a significant increase 
in serum levels of 25 (OH) vitamin D and calcium. There were significant reductions in diastolic 
blood pressure, heart rate, waist circumference, and serum fasting blood glucose, total) and low 
density lipoprotein)cholesterol after the nine)week period on vitamin D treatment, but no 
significant effects were observed on body mass index, systolic blood pressure, or serum high 
density lipoprotein)cholesterol and triglyceride. 
 vitamin D supplementation had beneficial effects on cardio)metabolic profile in 
adolescent girls. 
*vitamin D, cardiometabolic, supplementation, adolescent 


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Vitamin D, an essential micronutrient that is important for various aspect of human health. 
Vitamin D deficiency is now a prevalent global health problem, and is an important risk factor in 
the etiology of cancer, diabetes and cardiovascular disease (CVD) 
1
. The European Society for 
Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) has recently recommended 
that a serum 25)hydroxy vitamin D (25)OH D) level >50 nmol/l (20ng/ml) as the threshold value 
for vitamin D sufficiency 
2
. Hypovitaminosis D is particularly prevalent in Asia 
3
 with a reported 
prevalence of 90% in the Middle East 
3
 and 79% in Iran 
4
. The role of vitamin D is particularly 
important in adolescent girls, because vitamin D status influences various aspects of growth, 
development and puberty in this group 
5)7
. In Iran the prevalence of vitamin D deficiency has 
been reported to be 79)81.3% in adolescents 
8, 9
. 
Most chronic diseases, including CVD have their origins in childhood and adolescence, and the 
early control of their risk factors is important to reduce chronic disease  in adulthood 
10
. 
Several observational studies have indicated that serum 25)OH vitamin D is inversely associated 
with BMI, dyslipidemia, inflammatory markers and hypertension in children 
11)14
 and adults 
14, 15
. 
Low serum concentrations of 25)OH vitamin D are proposed to be related to cardiometabolic 
risk factors even in adolescence 
16
. However, vitamin D supplementation trials are necessary to 
clarify whether a low serum 25)OH vitamin D is causally related to these cardiometabolic risk 
factors. Several doses of vitamin D supplementation have been used previously in relation to  
affecting cardiometabolic risk factors 
16
, but the results from clinical trials have been 
inconsistent. Some clinical trials have suggested that vitamin D supplementation improve blood 
pressure, fasting blood glucose and lipid profile 
17, 18
, whilst other studies have not reported any 
significant improvements in these parameters 
19
. 
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Given the importance of vitamin D in health and the high prevalence of its deficiency in the 
community, Iran's Ministry of Health has recently used high)dose supplements of vitamin D for 
reducing vitamin D deficiency in adolescents. In this intervention, approximately 100000 
adolescent girls took nine high)doses 50000IU of vitamin D supplements, over a period of nine 
weeks. We have investigated the effects of this high)dose vitamin D supplementation on 
cardiometabolic risk factors in a random sample of this group of adolescent girls. To our 
knowledge, this study is one of the largest studies to date to examine the effects of high)dose 
vitamin D supplementation on cardiometabolic risk factors in adolescent girls. 
)

	
		
This study was undertaken in the cities of Mashhad and Sabzevar, in northeastern Iran between 
January and April 2015. Participants were selected by using a randomized clustering method and 
computer)generated random numbers. Written consent was obtained from the girls and their 
parents. We excluded girls with any auto)immune diseases, cancer, metabolic bone disease, 
hepatic or renal failure, cardiovascular disorders, malabsorption or thyroid, parathyroid or 
adrenal diseases. Subjects who were taking anti)inflammatory, anti)depressant, anti)diabetic, or 
anti)obesity drugs, vitamin D or calcium supplement use and hormone therapy within the last 
6months were also excluded. A total of 1026 adolescents aged 12)18 y old were screened; of 
whom, 988 met the inclusion criteria. All participants were provided with 9 vitamin D capsules 
containing 50000IU vitamin D over 9 weeks. Overall, 940 girls completed the intervention; with 
a dropout rate of 4.8%.  
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A validated food frequency questionnaire was used to evaluate dietary intakes 
20, 21
. To estimate 
energy and nutrient intakes, the reported portion size in FFQ were converted to grams using 
household measures and then were entered to the Nutritionist IV software. Physical activity was 
assessed through validated questionnaire 
22
 and provided as metabolic equivalents (METs) in 
hours per day. Demographic data, sun exposure and use of sunscreen were collected by an expert 
interviewer and by the use of a standard questionnaire. The ethical committee of Mashhad 
University of Medical Sciences approved the study, and informed written consent was completed 
by all participants. 
		
Anthropometric parameters were determined at baseline and after 9 weeks of intervention. Body 
mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. 
Waist circumference (WC), Systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
were measured based standard procedure. Heart rate (HR) was measured to count the number of 
heart beats occurring over a 60 second in sitting state and after 5)min rest.  
				
Fasting blood samples were obtained early in morning between 8 and 10 a.m. at baseline and 
after 9)weeks intervention, by venipuncture of an antecubital vein after a 14 h overnight fast. The 
samples were collected in vacuum tubes from subjects in a sitting position, according to a 
standard protocol. Blood samples were immediately centrifuged (Hettich model D)78532) at 
1465 3 g for 10 min at room temperature to separate serum, or plasma (0.5 ml). Samples were 
stored at )80° C at the reference laboratory in Mashhad University of medical science until 
analysis. An electrochemi)luminescence method (ECL, Roche, Basel, Switzerland) was used for 
the measurement of serum 25)OH vitamin D. The limit of detection for the 25)OH vitamin D 
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assay was 10 nmol/L for the ECL (Roche) and intra)and inter)assay variation were 5.7% and 
9.9%, respectively. Serum calcium (Ca), phosphate (P), fasting blood glucose (FBG), 
triglyceride (TG), total cholesterol (TC) and high density lipoprotein)cholesterol (HDL)C) 
concentrations were measured using commercial kits (Pars Azmun, Karaj, Iran) and the BT)3000 
auto)analyzer (Biotechnica, Rome, Italy). LDL)C was calculated using Friedewald formula if 
serum TGs concentrations were lower than 4.52 mmol/L 
23
. 
		
Kolmogrov)Smirnow test was applied to ensure the normal distribution of variables. We 
categorized the participants into three groups by baseline serum concentrations of 25)OH D: 
Deficient (<50 nmol/L), Insufficient (50)74.9 nmol/L) and Sufficient (>75 nmol/L). Significant 
differences in continuous variables across categories of 25)OH D were examined by use of the 
One)way analysis of variance (One)Way Anova); this analysis was also applied to compare the 
dietary intakes of population in along of the serum of vitamin D categories. A chi)squared test 
was used to assess the distribution of categorical variables across three groups of 25)OH D 
status. Partial correlation analysis was applied to evaluate the associations between 
anthropometric, biochemical parameters and changes of serum 25)OH D level after adjustment 
for age. To examine the effects of vitamin D supplementation on 25)OH D and cardiometabolic 
risk factors, we used paired t)tests. To control confounding factors (age, energy intake, dietary 
intake of vitamin D, menstruation, use of sunscreen, passive smoker, sun exposure, BMI and 
physical activity), we conducted analysis of covariance (ANCOVA). P)value <0.05 was 
considered statistically significant. All statistical analyses were performed using SPSS)17 (SPSS 
Inc., Chicago, Illinois, USA). 

Page 7 of 26
Annals of Clinical Biochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
DOI:10.1177_0004563217707784
8 
 


			
Of the 1026 girls invited to participate in the present study, 988 were eligible for inclusion. All 
988 subjects received capsules of 50000 IU of vitamin D, and 940 completed the 9 weeks follow 
up. Demographic characteristics of study participants are shown in Table 1. The mean age was 
significantly different between three groups defined by baseline 25)OH vitamin D status (p)
value= 0.01), but no significant difference was seen for all other parameters (passive smoker, 
location of residence, menstruation, use of sun screen and its protection factor, and the area over 
which it was used) and physical activity. Dietary energy, carbohydrate, protein, saturated fatty 
acid, mono)unsaturated fatty acid, fiber, vitamin D, vitamin E, vitamin C, sodium, calcium and 
zinc did not differ in the groups of vitamin D status. Intakes of total fat, polyunsaturated fatty 
acid, cholesterol and vitamin A was significantly different between vitamin D categories (P)
values = 0.04, 0.03, 0.04, <0.001, respectively). The correlation between changes of serum 25)
OH vitamin D level and baseline anthropometric and biochemical parameter are indicated in 
Supplementary Table 1. After adjusting for age, changes of serum 25)OH D level was only 
related to serum calcium (R: 0.09, P)value: 0.03). Moreover, we did not find significant 
differences for anthropometric measurements between the three groups of vitamin D status 
before or after intervention (Table 2).  
Furthermore, the biochemical assessments of study participants were compared across 25)OH 
vitamin D categories at baseline and after supplementation (Table 3). There was a significant 
difference in the baseline concentrations of FBG between the three groups (P)value: 0.001). We 
observed that individuals with vitamin D deficiency had more significant increments for 25)OH 
vitamin D compared to the subject with sufficient levels of vitamin D (P)value <0.001).  
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Serum status of 25)OH D was classified based on the following threshold values (nmol/L): 
serum 25)OH D levels <50 deficiency, 50)74.9 insufficiency and >75 sufficiency 
1
. Deficiency 
of vitamin D was present in 90%, while 5.2% and 4.8% of participants indicated insufficient and 
sufficient levels of 25)OH D at the baseline, respectively. After intervention, the prevalence of 
vitamin D deficiency was reduced to 16.3%, while insufficiency and sufficiency levels were 
increased to 19% and 64.8% respectively. 
The effects of vitamin D supplementation on anthropometric measurements (Table 2) and 
biochemical profiles (Table 3) for the total population and for the three separate baseline 
categories of 25)OH vitamin D are shown in the respective tables. The findings for the total 
population were in line with findings in each baseline categories of 25)OH D. A significant 
reduction in WC (69.5±9.3 vs 70.2±9.1, P)value= <0.001), HR (80.7±13.2 vs 83.2±12.9, P)value 
<0.001) and DBP (60.6±12.9 vs 62.3±13.4, P)value= 0.001) were seen after intervention 
compared with baseline while no statistically significant differences were found for BMI and 
SBP. 
Serum levels of 25)OH vitamin D (90.9±38.6 vs 23.3±22.04, P)value= <0.001) and Ca 
(2.36±0.15 vs 2.47±0.15, P)value= <0.001) were increased significantly by the end of study 
compared to at the baseline. The high dose vitamin D supplementation resulted in a significant 
reduction in serum TC (4.2±0.72 vs 4.02±0.67, P)value <0.001), LDL)C (2.6±0.63 vs 2.4±0.53, 
P)value <0.001) and FBG (4.8±0.65 vs 4.7±0.54, P)value <0.001). We did not find any 
significant differences in serum levels of phosphate, TG and HDL)C before and after 
supplementation.  
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We adjusted the effects of vitamin D supplementation on anthropometric and biochemical 
measurements (adjusted for age, energy intake, dietary intake of vitamin D, menstruation, use of 
sunscreen, passive smoker, sun exposure, BMI and physical activity). We did not obtain any 
significant differences between the crude and adjusted model. After adjustment, differences 
between before and after supplementation values for DBP, HR, WC, 25)OH D, Ca, TC, LDL)C 
and FBG, remained statistically significant. No significant differences were observed for other 
variables included SBP, Phosphate, HDL)C and TG (Supplementary Table 2). 

We analyzed data from a large interventional study with the purpose of determining whether 
high)dose vitamin D supplementations have beneficial effects on cardiometabolic risk factors. 
Taking vitamin D supplements appeared to have beneficial effects on DBP, HR, serum 25)OH 
vitamin D, Ca, TC, LDL)C and FBG. The prevalence of vitamin D deficiency was 90% at 
baseline, while it was decreased to 16.3% after intervention. To the best our knowledge, this 
study is one of the first of its kind in the adolescent girls group. Taking high)dose 50000 IU)
vitamin D for 8 weeks is recommended for vitamin D deficiency 
24
. In our study, we prescribed 9 
high)dose vitamin D pearls (50000 IU/week cholecalciferol) over a period of 9 weeks. At the end 
of study, the mean of 25)OH vitamin D was raised to 90.9 nmol/L; it has been suggested that the 
health benefits of vitamin D are seen  for serum a 25)OH vitamin D of between 75)100 nmol/L
25
. 
In our study, vitamin D supplementation improved serum 25)OH vitamin D. Similar results were 
found for effect of vitamin D supplementation on serum 25)OH vitamin D in previous studies 
26)
28
. It has been reported that serum 25)OH vitamin D can be increased by approximately 1.5 to 2.5 
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nmol/L for every 100 IU of vitamin D ingested 
29
. When the serum 25)OH D is less than 37.4 
nmol/L, it is expected that serum 25)OH vitamin D  would increase by 5 to 7.5 nmol/L 
1
. 
An inverse association has been reported between serum 25)OH vitamin D and obesity in 
previous studies 
3
; also a recent meta)analysis confirmed that low levels of vitamin D are 
associated with higher levels of BMI 
30
. We observed that treatment with vitamin D supplements 
were associated with an improvement in WC in our population. It is possible that this was 
associated with changes in diet over the intervention period. However, higher serum 
concentrations of PTH are associated with increasing lipogenesis and deceasing lipolysis. PTH 
reduction following vitamin D intake, might be result in an improvement in some anthropometric 
indexes 
31
. Vitamin D can also reduce adipogenesis through reduction in the expression and 
activity of peroxisome proliferator)activated receptor)gamma in adipocytes 
32
. 
We found that vitamin D supplements were associated with a significant reduction in diastolic 
blood pressure, but no effect on systolic blood pressure. There is some evidence that vitamin D 
supplements may be improve blood pressure 
33)35
, although other studies using relatively short 
treatment periods, or low doses of vitamin D supplements have reported no significant effects 
36
  
particularly in individuals with sufficient serum levels of 25)OH vitamin D before 
supplementation 
37
. A meta)analysis has reported a reduction in SBP of 2.44 mmHg in vitamin 
D)treated subjects, but no any significant effect on DBP 
38
. Wamberg et al. have reported higher 
dose of vitamin D supplementation had not significant effect on blood pressure, although this 
may the results of a small sample size 
39
. The control of renin–angiotensin system by decreasing 
renin gene expression and regulation of parathyroid hormone (PTH) production by parathyroid 
cells has been suggested as one biological mechanisms for the effects of vitamin D on blood 
pressure 
40, 41
. Moreover, vitamin D through increment of calcium absorption improve blood 
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pressure via altering cellular concentrations of sodium and calcium ions 
42
. Further randomized 
controlled trial studies are needed to clear the actual effects of vitamin D on blood pressure. 
Vitamin D deficiency is identified as a risk factor for cardiovascular diseases 
1
. We found taking 
vitamin D supplements caused a significant reduction in HR. This finding is in agreement with a 
previous study in healthy subjects. Vitamin D deficiency may be associated with a suppression 
of resting cardiac autonomic activity 
43
. Parasympathetic nerve fibres or vagus nerve are known 
as regulators of the heart rate; activity of these nerves is related to slow the heart rate 
44
. In 
individuals with low serums of vitamin D, cardio)protective vagal tone declined in response to 
an acute vascular stressor 
45
; it seems that 1,25)dihydroxy vitamin D may act as an important 
mediator in reducing vagal tone and therefore heart rate 
46
. 
We observed that vitamin D supplementation led to significant change in serum calcium, but not 
in serum phosphorus. Mozaffari)Khosravi et al. confirmed our findings in terms of effects of 
vitamin D on serum calcium and phosphorus 
34
. The absorption of calcium and phosphate are 
increased by vitamin D through various pathways 
47
. Intake of excessive vitamin D can cause 
hypercalcemia and hyperphosphatemia 
48
 but this may be related to baseline status. 
Vitamin D deficiency is considered as a potent risk factor for the development of impaired 
glucose metabolism and type 2 diabetes 
49
. Vitamin D deficiency or insuffiency has been 
reported to cause a 2)5 fold higher risk of enhanced blood glucose level in children 
50
. We found 
that vitamin D supplementation led to a significant reduction in FBG. Several studies have 
demonstrated a favorable effect of vitamin D on glycemic control 
51, 52
, while some others did 
could not find any significant effect 
53, 54
 which may be due to small sample size, normal FBG of 
study participants at baseline or relatively short treatment period. 
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In has been reported that, calcium)vitamin D co supplementation resulted in a significant 
reduction in FPG, serum insulin levels and HOMA)IR 
55
. Nikooyeh et al. found that vitamin D 
alone and vitamin D plus calcium yogurt drink caused a reduction decrease in HOMA)IR, FPG 
and Hemoglobin A1C in individuals with type 2 diabetes 
56
. The exact mechanisms that are 
involved in terms of effect of vitamin D in glucose metabolism are unclear. Vitamin D 
supplementation may improve glucose metabolism via more production of 1, 25)dihydroxy 
vitamin D, which, in turns, leads to increased expression of insulin gene and then enhanced 
insulin action, synthesis and release 
57
. Moreover, low 25)OH vitamin D levels may be 
associated with an increased production of PTH, which has been related to insulin resistance 
58
. 
Furthermore, improved calcium status and increased local production of 25)OH D may result in 
higher insulin sensitivity 
59
.  
Vitamin D status is known as an important factor in pathogenesis of cardiovascular disease. 
Serum 25)OH D and 1, 25)dihidroxy vitamin D concentrations are inversely associated with the 
presence of coronary artery diseases. 
In present study, a reduction in serum TC and LDL)C were associated with vitamin D 
supplementation, but no any significant effect was observed for HDL)C and TG. In line with our 
findings, some studies have previously demonstrated significant beneficial effects on lipid 
profiles 
60, 61
, while others did not report any improvement 
55, 62
. These inconsistent results may 
be due to different characteristics of population, study design, different of dosage 
supplementation and confounder variables. The mechanism of the effect of vitamin D on lipid 
profiles largely is unknown. Vitamin D intake can improve lipid profile by reduction in PTH 
level 
63
. It is likely which vitamin D affects lipid profiles thorough improvement of insulin 
sensitivity. Insulin decreases biosynthesis of cholesterol via increased β)hydroxy)β )
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methylglutaryl coenzyme A reductase activity 
64
. It has also been proposed that vitamin D might 
be correct lipid profile via increasing calcium absorption 
65
. It seems that long)term interventions 
are required to show the effects of vitamin D supplementation on lipid profiles.  
The main strength of the present study is large sample size for intervention. Second strength of 
the present study design was that it was performed in apparently healthy adolescent girl’s aged 
12–18 y. Moreover some limitations need to be considered in the interpretation of our findings. 
Also we were unable to measure PTH in our population, supporting the need for evaluation of 
this marker before and after vitamin D supplementation.  Owing to advice of our ethics 
committee, we were not able to have a control group in the present study. The relatively short 
duration of supplementation was another limitation in our study. The short intervention and bolus 
dose may have resulted in some of the null effects obtained in this study compared with previous 
studies of vitamin D supplementation.  
In conclusion, high)dose vitamin D supplementation with 50000 IU/ week for 9 weeks in 
apparently healthy adolescent girls led to improvement in WC, DBP, HR, 25)OH D, FBG, LDL)
C, TC, Ca; but it did not affect BMI, SBP, TG, HDL)C and phosphate. Future clinical trial 
studies are recommended to clear the effects of vitamin D supplementation on cardiometabolic 
risk factors in adolescents.  

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